| Quarterly Financials | Jun 2018 | Sept 2018 | Dec 2018 | Mar 2019 | Jun 2019 | Sept 2019 | Dec 2019 | Mar 2020 | Jun 2020 | Sept 2020 | Dec 2020 | Mar 2021 | Jun 2021 | Sept 2021 | Dec 2021 | Mar 2022 | Jun 2022 | Sept 2022 | Dec 2022 | Mar 2023 | Jun 2023 | Sept 2023 | Dec 2023 | Mar 2024 | Jun 2024 | Sept 2024 | Dec 2024 |
Revenue  | 16 | 15 | 12 | 17 | 13 | 14 | 16 | 16 | 7 | 16 | 17 | 19 | 16 | 19 | 20 | 18 | 18 | 19 | 19 | 20 | 23 | 21 | 24 | 22 | 26 | 26 | 26 |
| Expenses | 15 | 14 | 13 | 15 | 13 | 14 | 15 | 15 | 8 | 15 | 16 | 17 | 14 | 18 | 18 | 16 | 15 | 17 | 19 | 20 | 21 | 21 | 25 | 22 | 25 | 26 | 27 |
| EBITDA | 1 | 1 | -1 | 3 | 1 | -0 | 1 | 1 | -1 | 1 | 2 | 2 | 1 | 1 | 2 | 2 | 3 | 2 | -0 | -0 | 2 | 0 | -0 | 1 | 1 | 0 | -1 |
| Operating Profit % | 4 % | 4 % | -7 % | 2 % | 3 % | -2 % | 7 % | 5 % | -12 % | 4 % | 7 % | 2 % | 8 % | 3 % | 8 % | 9 % | 15 % | 8 % | -0 % | -2 % | 6 % | -1 % | -3 % | 0 % | 4 % | -0 % | -4 % |
| Depreciation | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 0 | 0 | 0 | 2 | 1 | 1 | 1 | 1 | 1 | 1 | 1 |
| Interest | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 1 | 0 | 0 | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 1 | 0 | 0 | 0 | 1 | 0 | 1 | 1 | 1 | 1 |
| Profit Before Tax | -0 | -0 | -2 | 1 | -1 | -1 | -0 | -0 | -2 | -0 | -0 | 1 | 0 | -0 | 1 | 1 | 2 | 1 | -1 | -2 | 1 | -1 | -1 | -1 | 0 | -1 | -2 |
| Tax | -0 | 0 | 0 | -1 | -0 | -0 | -0 | -0 | -0 | -0 | -0 | -0 | 0 | 0 | 0 | -0 | -0 | 0 | 0 | -0 | 0 | 0 | 0 | 0 | -0 | 0 | 0 |
| Net Profit | -0 | -0 | -2 | 2 | -1 | -1 | 0 | -0 | -2 | -0 | 0 | 1 | 0 | -0 | 1 | 1 | 2 | 1 | -1 | -2 | 1 | -1 | -1 | -1 | 0 | -1 | -2 |
| EPS in ₹ | -1.16 | -0.56 | -4.46 | 2.96 | -1.55 | -2.59 | 0.01 | -0.66 | -3.68 | -0.50 | 0.16 | 2.23 | 0.27 | -0.67 | 1.63 | 1.29 | 3.84 | 1.68 | -2.05 | -3.80 | 1.04 | -2.32 | -2.48 | -1.81 | -0.50 | -2.41 | -4.03 |
GKB Ophthalmics
74.98
-0.02
(-0.03%)
Market Cap
37.79 Cr
EPS
-5.58
PE Ratio
-
Dividend Yield
0.00 %
Industry
Healthcare52 Week High
136.40
52 Week low
71.55
PB Ratio
0.65
Debt to Equity
0.19
Sector
Medical Equipment
Live Chart 
Investment Returns
In Long Term
In Short Term
1 Year
0.00%
2 Years
0.00%
3 Years
0.00%
4 Years
0.00%
5 Years
0.00%
Peer Comparison Compare Peers on Screener
| Competitors | LTP | Market Cap (₹ Cr.) | P/E Ratio | Revenue (₹ Cr.) | YoY Revenue Growth % | Net Profit (₹ Cr.) | YoY Profit Growth % | RSI |
|---|---|---|---|---|---|---|---|---|
| 2,219.90 | 22,493.30 | 70.99 | 1,434.50 | 24.59 | 258 | 31.08 | 47.48 | |
| 305.55 | 1,625.72 | 54.79 | 307.90 | -0.45 | 43 | -46.46 | 39.64 | |
| 403.00 | 483.72 | 28.37 | 59.30 | 30.58 | 16 | 25.00 | 32.89 | |
| 232.53 | 232.53 | - | 102.40 | -13.51 | -2 | -1,500.00 | 33.35 | |
| 221.05 | 118.30 | 74.43 | 17.80 | 136.23 | 2 | -98.33 | 32.43 | |
| 96.00 | 100.18 | 10.15 | 109.90 | -1.43 | 10 | - | 31.13 | |
| 125.00 | 41.30 | 82.78 | 14.00 | 27.27 | 1 | - | 84.07 | |
| 44.50 | 38.53 | 20.59 | 32.30 | 14.13 | 3 | 0.50 | 33.63 | |
| 74.98 | 37.79 | - | 89.80 | 17.54 | -3 | -35.71 | 38.23 | |
| 92.10 | 33.60 | 49.19 | 51.30 | -2.84 | 1 | -400.00 | 36.55 |
Growth Rate
Revenue Growth
17.54 %
Net Income Growth
-3,100.00 %
Cash Flow Change
252.35 %
ROE
-2,829.41 %
ROCE
-150.20 %
EBITDA Margin (Avg.)
-61.53 %
Quarterly Financial Results
Balance Sheet
| Balance Sheet | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 |
| Total Assets | 75 | 69 | 82 | 83 | 93 | 102 | 107 | 110 | 112 | 115 |
| Fixed Assets | 12 | 13 | 18 | 18 | 26 | 26 | 24 | 23 | 19 | 18 |
| Current Assets | 46 | 51 | 63 | 64 | 64 | 73 | 74 | 76 | 84 | 88 |
| Capital Work in Progress | 1 | 1 | 1 | 0 | 0 | 0 | 1 | 3 | 4 | 4 |
| Investments | 0 | 6 | 4 | 0 | 1 | 1 | 2 | 2 | 2 | 2 |
| Other Assets | 63 | 50 | 60 | 64 | 67 | 75 | 80 | 82 | 87 | 91 |
| Total Liabilities | 75 | 69 | 82 | 83 | 93 | 102 | 107 | 110 | 112 | 115 |
| Current Liabilities | 33 | 23 | 33 | 36 | 37 | 41 | 38 | 39 | 41 | 46 |
| Non Current Liabilities | 2 | 2 | 2 | 2 | 2 | 2 | 2 | 4 | 4 | 4 |
| Total Equity | 40 | 45 | 47 | 45 | 55 | 59 | 66 | 67 | 67 | 64 |
| Reserve & Surplus | 36 | 41 | 43 | 41 | 47 | 54 | 58 | 58 | 58 | 55 |
| Share Capital | 4 | 4 | 4 | 4 | 5 | 5 | 5 | 5 | 5 | 5 |
Cash Flow
| Cash Flow | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 |
| Net Cash Flow | 1 | 0 | -1 | 0 | 7 | 4 | -7 | -0 | -4 | 1 |
| Investing Activities | -1 | 15 | 4 | 1 | -10 | -4 | -17 | -4 | 1 | -2 |
| Operating Activities | 7 | -11 | -3 | -3 | 4 | 3 | 7 | 5 | -3 | 4 |
| Financing Activities | -6 | -3 | -1 | 1 | 13 | 4 | 3 | -2 | -2 | -2 |
Share Holding
| % Holding | Mar 2021 | Jun 2021 | Sept 2021 | Dec 2021 | Mar 2022 | Jun 2022 | Sept 2022 | Dec 2022 | Mar 2023 | Jun 2023 | Sept 2023 | Dec 2023 | Mar 2024 | Jun 2024 | Sept 2024 | Dec 2024 |
| Promoter | 59.44 % | 59.24 % | 59.58 % | 59.69 % | 59.72 % | 59.73 % | 59.16 % | 59.09 % | 59.09 % | 59.18 % | 50.86 % | 50.88 % | 50.93 % | 50.95 % | 50.95 % | 50.98 % |
| FIIs | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 1.79 % | 1.79 % | 1.79 % | 1.79 % | 1.79 % | 1.79 % |
| DIIs | 0.39 % | 0.39 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.01 % | 0.01 % | 0.01 % | 0.01 % | 0.01 % | 0.01 % | 0.01 % | 0.00 % | 0.00 % | 0.00 % |
| Government | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % |
| Public / Retail | 23.93 % | 24.44 % | 24.90 % | 24.48 % | 24.63 % | 24.79 % | 24.82 % | 24.79 % | 27.11 % | 27.40 % | 36.01 % | 36.04 % | 36.04 % | 36.64 % | 36.34 % | 36.96 % |
| Others | 16.24 % | 15.93 % | 15.52 % | 15.83 % | 15.65 % | 15.47 % | 16.01 % | 16.11 % | 13.79 % | 13.41 % | 11.34 % | 11.28 % | 11.23 % | 10.63 % | 10.93 % | 10.27 % |
| No of Share Holders | 1,185 | 1,545 | 1,430 | 1,434 | 1,432 | 1,443 | 1,443 | 1,637 | 1,933 | 2,030 | 2,115 | 2,233 | 2,370 | 2,690 | 2,510 | 2,539 |
Dividend History
Dividends per share (FY)
Dividend yield (FY) %
| Annual Cash Flows | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|---|---|
| Dividend Per Share (₹) | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Dividend Yield (%) | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Corporate Action
Login to View
This information is available only for users of ScanX and Dhan.To proceed ahead,
LoginOpen Account
Announcements
Announcement under Regulation 30 (LODR)-Newspaper Publication
Integrated Filing (Financial)
GKB- Unaudited Standalone And Consolidated Financial Results For The Quarter And Nine Months Ended December 31 2024
Board Meeting Outcome for Outcome Of The Board Meeting Of GKB Ophthalmics Limited Held On February 13 2025
GKB Ophthalmics Limited Integrated Filling(Governance) For The Quarter Ended December 31 2024
Board Meeting Intimation for Consider And Take On Record The Unaudited Standalone And Consolidated Financial Results Of The Company For The Quarter And Nine Months Ended December 31 2024.
Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations 2018
Change In Name Of Registrar And Share Transfer Agent("RTA")
Outcome Of The Board Meeting Held On January 03 2025 And Execution Of Loan Agreement
Sanctioning Of Loan Amount Of Rs. 5.00 Crores By Subsidiary Company To GKB Ophthalmics Limited Holding Company.
Announcement under Regulation 30 (LODR)-Code of Conduct under SEBI (PIT) Regulations 2015
Announcement under Regulation 30 (LODR)-Code of Conduct under SEBI (PIT) Regulations 2015
Closure of Trading Window
Announcement under Regulation 30 (LODR)-Code of Conduct under SEBI (PIT) Regulations, 2015
Announcement under Regulation 30 (LODR)-Newspaper Publication
Submission Of Consolidated Related Party Transaction As On September 30, 2024
Unaudited Standalone And Consolidated Financial Results For The Quarter And Half Year Ended September 30, 2024.
Board Meeting Outcome for Outcome Of The Board Meeting Held On November 14, 2024 To Take On Record The Unaudited Standalone And Consolidated Financial Results For The Quarter And Half Year Ended September 30, 2024.
Board Meeting Intimation for Approval Of Unaudited Standalone And Consolidated Financial Results For The Quarter And Half Year Ended September 30, 2024
Compliances-Reg. 39 (3) - Details of Loss of Certificate / Duplicate Certificate
Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations, 2018
Closure of Trading Window
Submission Of Minutes Of 42Nd Annual General Meeting Of The Company Held On 20Th August , 2024.
Compliances-Reg. 39 (3) - Details of Loss of Certificate / Duplicate Certificate
Outcome Of The Board Meeting Held On August 31, 2024 And Signing Of Loan Agreement
Scrutinizer''s Report_Voting Results Of The Annual General Meeting Held On August 20, 2024
Shareholder Meeting / Postal Ballot-Outcome of AGM
Announcement under Regulation 30 (LODR)-Newspaper Publication
Statement Of Deviation(S) Or Variation(S) Under Regulation 32 Of SEBI ( Listing Obligations And Disclosure Requirements) Regulations, 2025 - June 30, 2024
Unaudited Standalone And Consolidated Financial Results Of The Company For The Quarter Ended June 30, 2024
Board Meeting Outcome for Outcome Of The Board Meeting Of GKB Ophthalmics Limited Held On August 13, 2024 For Approval Of Unaudited Standalone And Consolidated Financial - Quarter Ended June 30, 2024
Announcement under Regulation 30 (LODR)-Newspaper Publication
Notice For Book Closure -Annual General Meeting 2023-24.
Reg. 34 (1) Annual Report.
Board Meeting Intimation for Approval Of Unaudited Financial Results For The Quarter Ended June 30, 2024.
Announcement under Regulation 30 (LODR)-Newspaper Publication
Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations, 2018
Closure of Trading Window
Compliances-Reg. 39 (3) - Details of Loss of Certificate / Duplicate Certificate
Announcement under Regulation 30 (LODR)-Code of Conduct under SEBI (PIT) Regulations, 2015
Announcement under Regulation 30 (LODR)-Code of Conduct under SEBI (PIT) Regulations, 2015
Extract Of Statement Of Audited Standalone And Consolidated Financial Results For The Year Ended March 31, 2024.
GKB- Submission Of Consolidated Related Party Transactions For The Half Year Ended March 31, 2024
Statement Of Deviation(S) And Variation(S) Under Regulation 32 Of SEBI ( Listing Obligations And Disclosure Requirements ) Regulations, 2015 - March 31, 2024
Compliances-Reg.24(A)-Annual Secretarial Compliance
GKB - Audited Standalone And Consolidated Financials For The Quarter And Year Ended March 31, 2024
Board Meeting Outcome for Outcome Of Board Meeting Of GKB Ophthalmics Limited Held On May 30, 2024.
Intimation Under Regulation 30 Of SEBI ( Listing Obligations And Disclosure Requirements) Regulations, 2015 -Appointment Of Independent Director, Cessation Of Independent Director And Re-Constitution Of Committees Of The Board.
Board Meeting Intimation for Approval Of Audited Standalone And Consolidated Financial Results For The Quarter And Year Ended March 31, 2024.
Compliance Certificate Under Regulation 40(9)& 40(10) Of SEBI (Listing Obligations And Disclosure Requirements) Regulation ,2015 For The Year Ended March 31, 2024.
Company Filings to Exchanges
Feb 2025
Technical Indicators
RSI(14)
Neutral 38.26
ATR(14)
Less Volatile 5.63
STOCH(9,6)
Neutral 24.51
STOCH RSI(14)
Neutral 74.69
MACD(12,26)
Bearish -0.06
ADX(14)
Weak Trend 24.43
UO(9)
Bearish 33.27
ROC(12)
Downtrend And Accelerating -10.27
WillR(14)
Oversold -80.23
we are part of Raise Financial Services
built with love
for indians who love to invest & trade
Market Community
Follow us on
